Eucalyptus 指责澳大利亚医疗监管机构突然改变远程医疗指南，损害了患者的治疗结果。 Eucalyptus accuses Australian medical regulators of damaging patient outcomes with sudden telehealth guideline changes.

科技初创公司 Eucalyptus 指责澳大利亚医疗监管机构在没有足够数据的情况下对远程医疗处方指南进行大幅修改，损害了患者的治疗结果。 Eucalyptus, a technology start-up, accuses Australian medical regulators of damaging patient outcomes by making drastic changes to telehealth prescribing guidelines without sufficient data. 该公司声称它遵守医学委员会的指导方针，并且其平台为用户提供详细的预咨询调查问卷。 The company claims it complies with Medical Board guidelines and that its platform offers detailed pre-consultation questionnaires for users. Eucalyptus 首席执行官 Tim Doyle 批评传统的全科医生-患者模式在现代社会已经过时。 Eucalyptus CEO Tim Doyle criticizes the traditional GP-patient model as outdated in modern society.